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Artemisinin is extracted from the Asian plant Artemisia annua L. It has been proven to be, with its 
derivatives, the molecules that have shown so far the most powerful activity on malaria, even in its complicated 
forms and resistance cases. To resolve the problem of low aqueous solubility of this molecule, the use of 
cyclodextrins (CDs) was envisaged and gave good results in this topic. However, the impact on its stability and 
in vitro dissolution, important parameters for drug formulation and evaluation, was not evaluated. In this study, 
stability in accelerated degradation conditions andin vitro dissolution analysis of artemisinin were performed 
in comparison with complexes of artemisinin and cyclodextrins. The findings of this work allowed us to 
suggest that CDs improve the stability of artemisinin, especially when it’s in aqueous solution. We also 
demonstrated the beneficial impact of cyclodextrins o  the in vitro dissolution of artemisinin from capsules 
prepared with rough extracts of A. annua. 
© 2012 International Formulae Group. All rights reserved. 
 




Malaria, a parasitic disease, is still a 
problem of public health in more than hundred 
countries. This represents about 2.4 billion 
people and 40% of the world population.  The 
sub-Saharan African countries are particularly 
affected. Against this terrible infection, 
artemisinin and its derivatives have been 
proved to be the most effective drugs, as well 
in the simple forms as in complicated ones 
and also effective in the chloroquino-resistant 
forms (Ferreira and Janick, 1995; White, 
1999; Nosten et al., 2000). Thus they are 
recommended by WHO since 2001 for 





malaria treatment in Artemisinin Combined 
Therapy (ACT). However, the low aqueous 
solubility and high first-pass metabolism of 
artemisinin involve a poor and variable 
bioavailability (Titulaer et al., 1990). This 
may create problems of recrudescence and 
resistance at long-term. So, improving 
aqueous solubility of artemisinin may help to 
better bioavailability and cyclodextrins can be 
used for this purpose. 
Cyclodextrins (CDs) are cyclic 
oligosaccharides made of six, seven, or eight 
(for α-, β- and γ-cyclodextrin, respectively) 
glucose units bound by 1,4-ether linkages 
containing a relatively hydrophobic central 
cavity and hydrophilic outer surface. By 
exchange with the water molecules present in 
their cavity in the crystalline state, 
cyclodextrins are able to include large organic 
molecules by noncovalent interactions forces 
(Frömming and Szejtli, 1994) leading to an 
increase of aqueous solubility and stability of 
these molecules (Loftsson and Brewster, 
1996). However, this phenomenon is not 
always verified for all the substances; in fact 
the complexation ability depends on the 
geometry of the guest molecule inside the CD 
cavity and also its charge and polarity criteria 
(Frömming and Szejtli, 1994). 
The interactions between artemisinin 
and different CDs was previously studied 
(Zime-Diawara et al., 2012) and it was 
concluded that there is no real inclusion. 
Artemisinin formed with the tested CDs non - 
inclusion complexes. In view of using these 
complexes in pharmaceutical preparations, 
one must know if this kind of complexes also 
influences stability of the molecule and its in 
vitro dissolution capacities. 
In this study, we investigated the 
influence of artemisinin complexation with 
CDs on its stability and in vitro dissolution. 
The case of Crysmeb, a new generation of 
methylated β-cyclodextrin with a low degree 
of substitution (0.4 – 0.7), was particularly 
analysed. 
 
MATERIALS AND METHODS 
Materials 
Standard artemisinin (ARTE, 98%) was 
purchased from Sigma-Aldrich (Darmstadt, 
Germany). 
β-Cyclodextrin (βCD, 12.76% H2O) 
was provided from Wacker-Chemie GmbH 
(Munich, Germany). Kleptose® Crysmeb 
(Crysmeb, D.S.  , 3.99% H2O) was obtained 
from Roquette Frères (Lestrem, France). 
The seedlings of Artemisia annua used 
in this study were provided by the Laboratory 
of Applied Ecology of the Agronomic Faculty 
of Sciences of Abomey Calavi University in 
Benin. In fact, this Asian plant was 
acclimatized and set in culture in Benin. The 
seeds were obtained from Anamed 
(Winnenden, Germany). 
Ethanol (Ph Eur 96%) was acquired at 
VWR (Fontenay-sous-bois, France). Methanol 
was HPLC-Grade and was purchased, with 
KOH from VWR. All the other reagents 
(monopotassic and dipotassic phosphate and 
phosphoric acid 98%) were of analytical grade 
and acquired at Merck (Darmstadt, Germany) 




Preparation of Cds-Arte Complexes 
Excess amount of artemisinin were 
added to aqueous cyclodextrins solutions: 
βCD (10 mM) and Crysmeb (50 mM). The 
flasks were then shaken continuously in a 
thermostatically controlled water bath set at 
37 °C for 48 hours. This equilibrium time was 
determined experimentally by testing different 
times from 12 to 96 hours. All the conditions 
were realized in triplicate. After equilibrium 





was attained, suspensions from the flasks were 
filtered through 0.45 µm PVDF membrane.  
After this step of inclusion, the mixtures were 
filtered and the resulting filtrates were freeze-
dried to obtained ARTE- βCD and ARTE-
Crysmeb complexes powders. 
Characterization of Cds-Arte Complexes 
This step was realized by Differential 
Scanning Calorimetry analysis (DSC) using a 
Mettler Toledo Star apparatus. 
We examined different powders: artemisinin 
only, CDs only, complexes of 
artemisinin/CDs and physical mixtures of 
artemisinin with the CDs. All the samples 
were freeze-dried before the analysis. The 
temperature range went from 35 °C to 200 °C 
with a speed of 10 °C/min. 
The physical mixtures were prepared by 
mixing freeze dried artemisinin powder and 
freeze dried CDs powder in a mortar in the 
same proportions as in the complexes 
powders. 
Stability studies 
Stability studies were done at solid and 
liquid states on ARTE only, ARTE-βCD and 
ARTE-Crysmeb complexes. The conditions 
applied were a temperature of 40 ± 2 °C and 
relative humidity of 75 ± 5 during 2 months. 
These conditions correspond to subtropical 
area with possibilities of high humidity 
according to ICH classification. 
For study in solid state, powder of the 
3 compounds stored in the accelerated 
degradation conditions were weighted at each 
time of quantification and put in solution 
before prederivatization and analyze by 
HPLC. 
For study in liquid state, solutions of 
the 3 compounds were realized at the 
beginning of the work (J1). These 
preparations were done with sterilized 
material under laminar flow cabinet and 
conditioned in several individual 1.5 mL –
vials to avoid microbial proliferation.  These 
vials were stored at the conditions already 
specified. 
Periodic collections were realized over 
2 months (days 1, 3, 7, 14, 30, 45 and 60) for 
HPLC quantification.  
In vitro dissolution studies 
This study enters in a general topic of 
using Artemisia annua rough extracts to 
prepare antimalaric treatments. In fact, 
extracts of this plant can be obtained by non 
complicated operations and they contain other 
compounds which can be interesting in 
malaria treatment (with antipyretic properties, 
potentiation of artemisinin’s antimalaric 
activity) (Elford et al., 1987). 
So capsules were made with hydro 
alcoholic extracts of Artemisia annua (called 
capsules A). After that, we also made capsules 
containing this extract added to Arte-βCD and 
Arte-Crysmeb complexes respectively (called 
capsules B and C). The total artemisinin 
content was equal in these three kinds of 
capsules (approximately 8 mg/capsule). 
The in vitro dissolution of the 3 kinds 
of capsules A, B and C was determined by 
using the paddle method (ERWEKA type 
DT6-K, Germany) in 500 mL of HCl (0.001 
M), under sink conditions. The paddle rotation 
speed was set at 100 rpm. The temperature 
was maintained at 37±0.5 °C. Samples of 20 
mL were collected at 15, 30, 45 and 60 
minutes and were directly filtered. The 
filtrates were derivatized (as described below) 
and then quantified by HPLC. 
Quantification of artemisinin 
UV detection of artemisinin is not easy, 
due to the lack of chromophores. So, it must 
be pre- or post- derivatized. We used in this 
study prederivatization inspired from Zhao 
and Zeng (1985) method which has been 
modified and validated in presence of CDs 
(Zime-Diawara et al., 2011).  





For the prederivatization, one ml of 
sample (extract solution or standard solution) 
was transferred into a 10 ml measuring flask. 
Four ml of 0.2% (m/v) NaOH solution was 
added in the flask, and then left to react at 50 
ºC for 30 min. After cooling for 10 min, 1 ml 
of ethanol was added. Finally the flask was 
filled with acetic acid 0.2 N. 
All solutions were filtered on a PTFE 
0.45 µm membrane before HPLC analysis. 
The HPLC apparatus used for artemisinin 
quantification was a Hitachi Alliance from 
VWR with LaChrom Elite software for data 
acquisition. 
Chromatographic separation was 
performed with a reversed phase RP-18 
LiChroCART column (250 mm × 4 mm I.D.; 
particle size: 5 µm). Mobile phase consisted in 
a mixture of methanol and phosphate buffer 
(0,005 M; pH: 6.3) (45/55, v/v). A flow rate of 
1 ml/min and detection at 260 nm were used. 
The column was maintained at 35 °C and the 





Figure 1: Thermograms of artemisinin only (in black), β-CD only (in red), complex of 











Figure 2: Thermograms of artemisinin only (in green), Crysmeb only (in blue), complex of 
artemisinin with Crysmeb (in red) and physical mixture of artemisinin and Crysmeb (in black); 





Figure 3: Compared stability in solid state of non complexed artemisinin (down), complexed with 
β-CD (middle) and Crysmeb (up). 







Figure 4: Compared stability in aqueous solution of non complexed artemisinin (down), complexed 






Figure 5: Dissolution profil of artemisinin from capsules A ( .annua only). N=6. 







Figure 6: Dissolution profil of artemisinin from capsules B (A. annua enriched with βCD/Arte 
complex on left) and from capsules C (A. annua enriched with Crysmeb/Arte complex on right). N=6 
in each case. 
 
 
RESULTS AND DISCUSSION 
DSC analyses 
Figures 1 and 2 show the thermograms 
obtained with β-CD and Crysmeb 
respectively. Each figure represents four 
thermograms: artemisinin only, CD only, 
physical mixture of artemisinin and the CD 
and complex of artemisinin with the CD. 
Artemisinin showed a melting point at 
153 °C. This value is close to that reported by 
Jinadasa (1996) for the orthorhombic 
polymorphic form of the drug. 
We can observe the disappearance of 
the peak of artemisinin on the thermogram of 
the complexes, which is the proof of the 
transformation of crystalline form in 
amorphous form. So, we have effective 
formation of complexes in this powder.  At 
the difference, in the physical mixtures, the 
presence of the two forms (amorphous and 
crystalline) is observed.   
The powders of complexes prepared 
are thus homogeneous and don’t contain any 
more non-complexed artemisinin.   
As it has been proved that there is no 
real inclusion of artemisinin in CDs (Zime-
Diawara et al., 2012), this analysis comes to 
confirm that the DSC analysis can’t be use to 
conclude on an inclusion or not. It is just an 
element to confirm or invalidate complexation 
of CDs with a molecule.  
 
Effect of cyclodextrins on artemisinin 
stability 
In solid state (Figure 3), complexation 
with CDs seemed to have no significant effect 
on stability of artemisinin after a sixty days 
observation with storage in conditions of 
accelerate degradation previously described. 
In fact, it remains 90% of non complexed 
artemisinin compared to 93% and 95% when 
artemisinin is complexed with β-CD and 
Crysmeb respectively. 
However, in aqueous solution (Figure 
4), we can note an important degradation 
(66%) for non complexed artemisinin while 
βCD/Arte and Crysmeb/Arte complexes 
showed moderate degradation (15% and 10% 
for β-CD and Crysmeb respectively) after 





sixty days storage stress. This suggested an 
improvement of artemisinin stability in 
solution when complexed with CDs.  
Ansari et al. (2009) have obtained the 
same results with dihydroartemisinin/HPβ-CD 
complexes. The complexes showed a 40% 
increase in thermal stability (50 °C) and a 29-
fold decrease in hydrolysis rates compared 
with dihydroartemisinin. 
Moreover, similar results of increasing 
stability from complexation and/or inclusion 
affinity with CDs were obtained with 
astaxanthin, warfarin, camptothecin, and taxol 
(Chen et al., 2007; Dordunoo and Burt, 1996; 
Kang et al., 2002; Zingone and Rubessa, 
2005). 
A comparison of the two type of 
complexes (Figure 4) shows that the 
degradation is a little more marqued with 
βCD/Arte complex than Crysmeb/Arte one. 
This could be explained by interactions more 
strong in Crysmeb/Arte complex than in 
βCD/Arte. The NMR results in the study of 
interactions of artemisinin with CDs (Zime-
Diawara et al., 2012) corroborate this 
hypothesis. 
 
In vitro dissolution studies 
The solubility of artemisinin in water is 
reported as 10.6 mg/L (Mueller et al., 2000) 
and 8.6 mg/L (Usuda et al., 2000). 
However, this solubility is improved 
when it is in A. annua extracts. In fact, 
Mueller et al. (2000)  obtained 10.6 mg/L with 
250 mg artemisinin in 1L water; while with 5g 
of A. annua containing 0.5% artemisinin (only 
25 mg artemisinin), they found 12.0 mg/L. 
This increase in solubility (ten fold 
increasing) was attributed to other constituents 
in the plant (flavonoid, glucosides or 
saponins) which may help to dissolve the 
lipophilic plant compounds in an aqueous 
medium. 
It has been proved that CDs increase 
the aqueous solubility of pure artemisinin 
(Usuda et al., 2000; Wong and Yuen, 2003; 
Zime-Diawara et al., 2012). We can thus 
expect that the in vitro dissolution of 
artemisinin will be improved by these 
molecules. However, a verification of this 
phenomenon is necessary, especially in the 
present situation where artemisinin is in form 
of plant extracts. 
Figures 5 and 6 show the dissolution 
profiles of artemisinin from the capsules A, B 
and C.We notice that the dissolution is better 
when artemisinin is complexed with a 
cyclodextrin. In fact, for the dissolution of 
artemisinin from capsules A, after 60 min, we 
reached 71% of solubilization (Figure 5) 
whereas with capsules B and C, we have 100 
and 85% respectively (Figure 6). 
The dissolution rate obtained with 
capsules of A. annua only (71%) is higher 
than that found by Hoa et al. (1996) for in 
vitro dissolution of pure artemisinin (60%). 
This confirm that the in vitro dissolution of 
artemisinin from preparations with extracts of 
A. annua is better than when it is in 
commercial preparations with pure 
artemisinin. The presence of the other 
constituents of the plant (flavonoids and other 
sesquiterpens) is thus important. 
 β-CD seems to have more impact than 
Crysmeb on artemisinin in vitro dissolution 
from Artemisia annua capsules. With β-CD, 
the dissolution is completed after 30 minutes.  
While with Crysmeb, the total dissolution is 
not reached but stabilization is obtained at 
about 80-85%. Thus, cyclodextrins increase 
the in vitro dissolution of artemisinin from 
Artemisia capsules and β-CD has a higher 
impact than Crysmeb. 
Similar results were obtained for tablets 
of pure artemisinin (Wong and Yuen, 2003). 
In fact, they concluded that the tested 
complexes (α-CD/Arte, β-CD/Arte and γ-
CD/Arte) showed an increased dissolution rate 
as compared with the commercial preparation 
of pure artemisinin. 





So, the presence of the other 
components of the extracts doesn’t hind the 
action of the CDs.  
This improvement of the in vitro 
dissolution suggested a possible beneficial 
impact on the bioavailabity of these 




This study shows that the complexation 
of artemisinin with cyclodextrins improves in
vitro dissolution and makes it possible to 
obtain a better stability of artemisinin in 
aqueous medium.  Crysmeb seems to have a 
light advantage compared to β-CD, in fact, the 
stability of capsules containing A. annua 
extract enriched with Crysmeb complex is 
better than those enriched with β-CD one . 
This is interesting for a development and 
distribution of galenic formulations in African 
countries. Even if its dissolution is lower than 
that of β-CD, it remains in conformity to the 
pharmacopeias recommendations.  
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